Schizophrenia

Schizophrenia:

Psychopathology:

  • Study of mental disorders such as progression, diagnosis, treatment.

  • This broad discipline draws on research from numerous areas like psychology, biochemistry, pharmacology, psychiatry, neurology, and endocrinology.

APA dictionary of Psychology:

  • The scientific exploration of abnormal mental states.

  • The discipline that assesses and makes sense of abnormal human subjectivity.


Limitations and challenges:

  • Measurements and categorization issues

  • Norms and neurodiversity (what is normal)

  • Blurry boundaries (do disorders fit into neat categories?)

  • Mental health vs medical conditions: fundamental differences


ICD-11

Diagnostic framework 

  1. Traditional categorical approach

  • Diagnostic tools: DSM-5 & ICD

  • Disorders are “present or absent”, not “continous”

  • Disorders are classified by discrete categories

  • Assuming you either meet criteria or don't, does not account for symptom severity or spectrum based disorders.

Key components:

  • Characteristic symptoms

  • Social/ occupational dysfunction

  • Duration of symptoms.


  1. Emerging Dimensional approach:

  • Research framework, not a diagnostic tool

  • RDoC

  • ^^organizes psychopathology by domains of functions, not disorders (negative valence, positive valence, cognitive systems, social processes, arousal/regulatory systems, sensorimotor systems)

Key principles:

  • Conceptualized mental illness as a brain disorder

  • Emphasized biomedical explanations

  • Moves away from descriptive diagnostic systems (DSM-5)


1 in 4 2022, psychopathology is common

​​Nearly one in five U.S. adults lives with a mental illness (44.7 million in 2016). Among adults aged 18 or older in 2022, 23.1% (or 59.3 million people) had any mental illness (AMI) in the past year.

Faces of Schizophrenia you may know:

  • John Nash

  • Pink Floyd

  • Eduard Einstein

  • Vincent Van Gogh

How common is Schizo?

  • Affects 20 million people worldwide

  • 3 million cases in the U.S

Misconceptions vs reality:

  • Schizo is often stigmatized as being linked to danger or “criminal insanity”

  • Scientific evidence does not support the idea that individuals with schizo are inherently violent.

  • exceptions:

Substance abuse: individuals with schizo who abuse drugs have a slightly higher risk or violent offenses.

Childhood conduct problems: those with a history of conduct disorder in childhood are more likely to commit violent crimes.


What is schizophrenia?

3 symptom categories:

  1. Positive deviant symptoms::

  • Hallucinations

  • Delusions

  • Disorganized speech

  1. Negative deficit symptoms:

  • “Flat affect” means reduced expression of emotions via facial expression or voice tone.

  • Reduced feelings of pleasure

  • Difficulty beginning or sustaining activities

  • Reduced speaking

  1. Cognitive symptoms:

  • Working memory deficits (Problems with “working memory” (the ability to use information immediately after learning it)

  • Trouble focusing

  • Poor executive function

  • Bizarre behavior

DSM-5: at least one positive symptom and two (total) symptoms for a significant portion of time during a one month period


Development of Schizo:

  • Diagnosed in the late teens year to early thirties

  • Tend to emerge earlier in males than females

  • Genetics (can run in the family, no single gene causes the disorder)

  • Environment (interactions between genetic risk and individuals environment)

  • Prenatal viral infection, maternal stress, hypoxia, childhood trauma, urban living cannabis use during adolescence)


Neural features that we see in schizo


  1. Disorganized Hippocampal Formation:

  • Alterations and dysfunction in the hippocampal structure may play a role in symptom manifestation

  1. Enlarged ventricles

  • Structural brain damage, enlargements of lateral and third ventricles

  1. Higher rate of gray matter loss — decreased frontal lobe activation.

  • Adolescents with schizo show a higher average annual loss of gray matter and decreased frontal lobe activity compared to normal adolescents.

  1. Dopamine dysregulation, and glutamate abnormalities


Antipsychotic drugs:

  • Medication required institutionalization for mental illness

Impact on institutionalization:

  • Antipsychotic medications have significantly reduced the need for institutionalization for mental illness.

Mechanism of Action:

  • Primary action on dopamine signaling (neuroleptics), which was identified in the 1960s

  • The 1970 brought the discovery of dopamine receptors, revealing that higher D2 receptor affinity correlates with clinical efficacy of antipsychotic medications.

Importance of Atypical antipsychotics:

  • 2nd generation antipsychotic target serotonin as well as dopamine receptors, which presents a multi-faceted approach to treatment.


Model of Aberrant Salience:

  • Proposes that psychotic symptoms first emerge when chaotic brain dopamine transmission leads to a shift in a stimuli significance.

  • Focuses more on stimuli that would normally be considered irrelevant.

The mechanism:

  • Delusions may stem from altered dopamine pathways that shift emotional and reward significance, thereby enhancing perceived threats and altering attention.

  • Too much dopamine = irrelevant cues feel meaningful

  • Too little dopamine = important cues feel less relevant

  • hallucinations= sensory experiences given too much salience

  • delusions= attempts to explain abnormal salience


Animal models of Schizo


  1. Neurodevelopmental models: inducing changes in brain development during gestation or perinatal periods

  2. Pharmacological models: creating drug- induced psychosis using substances like PCP,LSD and amphetamines

  3. Genetic manipulation technique: manipulating genetic expression to stimulate schizo in animal studies

  4. Prepulse inhibition (PPI): common behavioral test used to examine sensory processing deficits

  • PPI reflected ability to filter sensory information

  • schizophrenia= reduced ppi= impaired sensory gating

  1. Focus on Positive Symptoms: most studies primarily target positive symptoms; addressing how to model negative symptoms like flat affect remains a challenge


Translational considerations:


1st drug prozemene